Executive team
Mari Baker, President and CEO
Mari Baker was formerly president of BabyCenter, the world's leading Web site for new and expectant parents, and a senior vice president at Intuit, which she joined in 1989 as product manager for Quicken. Ms. Baker led the growth of Quicken into the No. 1 personal finance product in the world. She is also an emeritus trustee of Stanford University.
Dietrich Stephan, Ph.D., Co-founder and Chief Science Officer
Dietrich Stephan is a human geneticist on the faculty of the Translational Genomics Research Institute and chairman of the National Institutes of Health Neuroscience Microarray Consortium. He has identified genes that predispose to disorders such as autism, exercise-induced heart attacks and sudden infant death syndrome, and contributed to understanding a multitude of common disorders such as Alzheimer's disease.
Amy DuRoss, Vice President of Policy and Business Affairs
Amy DuRoss served as chief of staff for the California Institute for Regenerative Medicine, established in 2004 by the passage of Proposition 71, which provides $3 billion in funding for stem cell research in California.
Sean George, Ph.D., Chief Operating Officer
Before joining Navigenics, Dr. George held numerous posts at Affymetrix, Inc., most recently senior vice president of marketing, responsible for the company's marketing, corporate communications, product management and customer relationship management divisions. Dr. George also served as vice president of life science research at Affymetrix, leading the company's $200 million-dollar academic business in North America, Europe, Japan and China.
Stephen Moore, General Counsel
Mr. Moore was most recently associate general counsel with Affymetrix, Inc., a publicly traded biotechnology company developing advanced technologies for genetic screening. During his more than eight years at Affymetrix, he was responsible for a wide variety of strategic alliances, collaboration agreements and other transactional matters, including the spin-out of Perlegen Sciences, research collaborations with leading academic institutions such as the Broad Institute of MIT and Harvard, diagnostic product supply agreements and Affymetrix's Translational Medicine program in the United States and Canada.
Michael Nierenberg, M.D., Medical Director
Dr. Nierenberg has been the personal physician to many of Silicon Valley's CEOs, venture capitalists and lawyers, as well as prominent national and international figures. He has been mentioned frequently in local and national publications as a top internist. Dr. Nierenberg practiced internal medicine in Palo Alto and Menlo Park, California, for 30 years, serves as an emeritus clinical professor of medicine at Stanford University and consults in the legal and venture capital arena. Dr. Nierenberg is also medical advisor to Shalon Ventures, a company developing medical devices.
Becky Scott, Chief Financial Officer
Before joining Navigenics, Ms. Scott was vice president of finance and administration for BabyCenter, LLC, a wholly owned subsidiary of Johnson & Johnson. She was responsible for managing finance and all core administrative functions, including human resources, legal and facilities, as the company expanded from start-up stage to becoming the pre-eminent online parenting resource it is today. During her time at BabyCenter, she also acted as the company's chief privacy officer and was instrumental in the international rollout of nine new country-specific sites.
Denise Thomas, Chief Marketing Officer
Ms. Thomas has more than 20 years of experience in marketing and business management. She was formerly executive vice president and chief marketing officer for LesConcierges, a global loyalty and lifestyle services firm, and founder of OffRoad Capital, transforming a pioneering idea into a Web-driven marketplace that attracted more than 7,000 member investors with a net worth of $40 billion.
Vance Vanier, M.D., Chief Medical Officer
Dr. Vanier was formerly a partner at MDV-Mohr Davidow Ventures, where he invested in molecular diagnostics, medical devices and online health. In addition, he helped formulate the clinical and commercialization strategies of numerous portfolio companies operating in medical markets.
